# Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors

> **NCT04727554** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 11 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** AMG 994
- **DRUG:** AMG 404

## Key facts

- **NCT ID:** NCT04727554
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-29
- **Primary completion:** 2023-06-05
- **Final completion:** 2023-06-05
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2025-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04727554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04727554, "Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04727554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*